Fall 2024
In the Fall 2024 CIHR funding round, the Department of Medicine (DOM) secured over $14.5 million, accounting for 34% of the Faculty's total CIHR funding ²¹²Ô»åÌý29% of º«¹úÂãÎè’s total CIHR funding. This includes more than $12 million awarded to DOM researchers at the RI-MUHC, representing 70% of the RI-MUHC’s total CIHR funding, and over $2.4 million awarded to DOM researchers at the LDI, making up 43% of the LDI’s total CIHR funding. These results reflect a slight increase compared to the previous round.
Congratulations to the following º«¹úÂãÎè Department of Medicine project grant awardees for their successful Fall 2024 CIHR applications!
Project Grant Awardees (listed in alphabetical order by PI):
Dr. Matthew Cheng -ÌýA Randomized Controlled Trial of Oral Antimicrobial Therapy for Patients with Staphylococcus aureus Bacteremia: The Early Oral Switch Domain in the Staphylococcus aureus Network Adaptive Trial (EOS-SNAP)Â
Dr. Inés Colmegna -ÌýInvestigating the anti-fibrotic effects of human multipotent mesenchymal stromal cellsÂ
Dr. Stella S. Daskalopoulou -ÌýClinical Investigation – A: Reproduction, Maternal, Child and Youth Health 2Â
Dr. Gustavo Duque -ÌýInvestigating the Diagnostic and Therapeutic Role of the Kynurenine Pathway in OsteosarcopeniaÂ
Dr. Christina Greenaway -ÌýGetting to hepatitis B elimination in Canada: Where are the gaps and how best to fill them?
Dr. Sabah Hussain -ÌýRegulation of skeletal muscle and peroxisomal homeostasis by Depp1 proteinÂ
Dr. Bertrand Jean-Claude -ÌýEngineering metabolically stable molecules toward tandem targeting of EGFR, its variant EGFRvIII and DNA for killing stem cells and preventing recurrence in the treatment of glioblastom multiforme (GBM)Â
Dr. Todd C. Lee -ÌýAn international platform for finding the optimal therapies for Pneumocystis jirovecii pneumonia: The PCP PlatformÂ
Dr. Ivan Litvinov -ÌýCo-creating and implementing integrated dermatology care and augmenting skin research in Quebec northern Indigenous communitiesÂ
Dr. Basil Petrof  -ÌýThe role of trained macrophages in dystrophic diaphragm pathologyÂ
Dr. Louise Pilote -ÌýRole of Sex and Gender on Hypertension-mediated Multi-organ DamageÂ
Dr. Stéphane Richard -ÌýEpigenetic modulation to enhance CD8+ T cells for improved antitumour activityÂ
Dr. Abhinav Sharma -ÌýDelivering Evidence-Based Care Using Artificial Intelligence to Patients with Diabetes and CardioVascular Comorbidities: From Proof of Concept to Multi-Centre Expansion (DECIDE-CV-2)Â
Dr. Rhian Touyz -ÌýRho kinase as a novel therapeutic target in small vessel disease and vascular dementia – insights from a Notch3 disease
Dr. Oriana Hoi Yun Yu -ÌýThe association between levothyroxine treatment and the risk of metabolic dysfunction-associated steatotic liver disease among people with subclinical hypothyroidism
Priority Announcement Grant Awardees (listed in alphabetical order by PI):
Dr. Claire Godard-Sebillotte -ÌýAméliorer l’équité en première ligne pour les personnes avec troubles neurocognitifs majeurs: Une étude à méthodes mixtes axée sur le patient
Dr. Thomas Mavrakanas -ÌýEffect of Canagliflozin on Peritoneal Function and Fibrosis in Patients on Peritoneal Dialysis: a proof-of-concept randomized crossover clinical trial (CAN-PD trial)
Dr. Shaifali Sandal -ÌýDisaster risk reduction and management in kidney care to foster health system resilience
Dr. Giada Sebastiani -ÌýELITE-2D: Enhancing Liver Health for People with Type 2 Diabetes through Patient-Centred Strategies
Related: (CIHR website)Spring 2024
The Department of Medicine had the highest share of awards within the Faculty of Medicine and Health Sciences (31.6%) and submitted the most applications within the FMHS (accounting for 26% of all applications). In this round, the Department of Medicine garnered over $10 million in CIHR funding, representing 25% of º«¹úÂãÎè’s total CIHR funding for Spring 2024.
Congratulations to the following º«¹úÂãÎè Department of Medicine project grant awardees for their successful Spring 2024 CIHR applications!
Dr. Faiz Ahmad Khan -
Dr. Andrea Benedetti -
Dr. Sasha Bernatsky -
Dr. Yen-I Chen -
Dr. Maziar Divangahi - Programming Innate Memory Responses to promote host defense against SARS-CoV-2 Pneumonia
Dr. Jonathon Campbell -
Dr. Jacqueline Joza -
Dr. Nadine Kronfli -
Dr. Todd Lee -
Dr. Emily McDonald -
Dr. Jean-Pierre Routy -
Dr. Atul Verma -
Dr. Michael Goldfarb -
Fall 2023
The Department of Medicine received one of the highest shares of awards within º«¹úÂãÎè representing 17.8% of º«¹úÂãÎè’s total share of awards ($8.5 million). Excluding Priority Announcements and Bridge Grants, the DOM’s success rate was 21.2% (11 of 52).
Congratulations to the following DOM grant recipients for their successful Fall 2023 CIHR applications!
- Carolyn Baglole
- Andrea Benedetti (Priority Announcement)
- Sasha R Bernatsky (Priority Announcement)
- Yen-I Chen
- Stella S Daskalopoulou (Priority Announcement)
- Anne Gatignol (Priority Announcement)
- William J Muller
- Monzur Murshed
- Nitika Pant Pai (Priority Announcement)
- Stéphane Richard
- Christian E Rocheleau
- Shaifali Sandal
- Tomoko Takano
- George Thanassoulis
- Rhian M Touyz
- Oriana Hoi Yun Yu
The Department extends its sincere appreciation to the Canadian Institutes of Health Research (CIHR) and the Government of Canada for their continued support of medical research. This investment not only drives innovation and enhances patient care but also strengthens Canada’s position as a leader in global health research. We are proud to contribute to this shared mission and remain committed to advancing scientific discovery for the benefit of our communities.
2025-2026
º«¹úÂãÎè has submitted 73 applications to the Fonds de recherche du Québec – Santé (FRQS) for the 2025-2026 funding cycle, with the Faculty of Medicine and Health Sciences (FMHS) contributing 56. Notably, the Department of Medicine submitted 16 applications - the highest of any department at º«¹úÂãÎè.
These figures position the Department of Medicine as a leader in research submissions, accounting for 22% of the university’s total applications and 29% of those from the FMHS.
Results will be announced in the spring - stay tuned for updates as we track this important funding process.
2024-2025
The º«¹úÂãÎè Department of Medicine achieved an impressive 59% success rate in the FRQS competition, with 13 out of our 22 applicants receiving an award.
This year, the FRQS awarded six Chercheur(e) de Mérite awards province-wide. Remarkably, three of these were granted to the º«¹úÂãÎè Division of Cardiology.
Moreover, the department saw a notable success rate among its Chercheur(e) Boursier(e) Clinicien(ne) applications, with 9 out of 13 receiving awards. Additionally, one out of three Chercheur(e) Boursier(e) applications were successful.
Congratulations to the 2024-2025 DOM FRQS awardees:
Chercheur Boursier de Mérite
- Jonathan Afilalo
- Ariane Marelli
- George Thanassoulis
Chercheur Boursier Senior
- Andrea Benedetti
Chercheur Boursier Clinicien Senior
- Sushmita Pamidi
- Francois Tournoux
- Cedric Yansouni
Chercheur Boursier Clinicien Junior 2
- Deborah Assayag
- Yen-I Chen
Chercheur Boursier Clinicien Junior 1
- Amine Benmassaoud
- Jacqueline Joza
- Elena Netchiporouk
- Romina Pace
2023-2024
The Department of Medicine excelled in the FRQS salary award competition, with 14 applications funded in Spring 2023, out of the 19 submitted (74%). This represents the highest number of applications from any department, and the highest success rate for any department that submitted more than one application. This testifies to the strength of our MD and PhD scientists, including those at the most junior levels and to the comprehensive mentorship and support we strive to provide.
Congratulations to the 2023-2024 DOM FRQS awardees:
Chercheur Boursier de Mérite
- Dr. Dao Nguyen
- Dr. Vidal Essebag
Chercheur Boursier Clinicien Senior
- Dr. Benjamin Smith
- Dr. Evelyne Vinet
- Dr. Faiz Ahmad Khan
Chercheur Boursier Clinicien Junior 2
- Dr. Francois Mercier
- Dr. Abhinav Sharma
- Dr. Nadine Kronfli
Chercheur Boursier Clinicien Junior 1
- Dr. Carolyn Jack
- Dr. Chan Gao
- Dr. Claire Godard-Sebillote
- Dr. Patrick Lawler
Chercheur Boursier Junior 1
- Dr. Jonathon Campbell
- Dr. Paul Sabatini